Status:
ACTIVE_NOT_RECRUITING
Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay
Lead Sponsor:
Medacta International SA
Conditions:
Primary Osteoarthritis
Secondary Osteoarthritis
Eligibility:
All Genders
18+ years
Brief Summary
This is a post-marketing surveillance on MiniMAX Stem
Eligibility Criteria
Inclusion
- Patient with a clinical condition requiring THA
- Patient receiving a MiniMAX® stem
- Patient aged more than 18 years
- Patient having a Social Insurance or a similar protection regime
- Patient eligible for an AMIS procedure
- Patient able to follow the study requirements
- Patients who are willing to give informed written consent
Exclusion
- Patient with local or systemic infection
- Participation to biomedical research
- Patient whose BMI exceeds 40
- Patient with less than 18 years
- Protected adults
- Vulnerable person according to article L1121-6 of the Code de la Santè Publique.
- Pregnant or lactating woman
- Patient unable to express his/ her opinion about the participation to the study
Key Trial Info
Start Date :
January 2 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 2 2031
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06012656
Start Date
January 2 2019
End Date
January 2 2031
Last Update
September 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Clinical Angouleme Soyaux
Soyaux, France, France, 16800